Filter News
Area of Research
- (-) Neutron Science (12)
- Advanced Manufacturing (2)
- Biology and Environment (38)
- Clean Energy (53)
- Computational Biology (1)
- Fusion and Fission (5)
- Fusion Energy (1)
- Materials (24)
- Materials for Computing (7)
- National Security (4)
- Nuclear Science and Technology (2)
- Quantum information Science (1)
- Supercomputing (45)
News Type
News Topics
- (-) Coronavirus (8)
- (-) Frontier (1)
- (-) Polymers (1)
- (-) Sustainable Energy (2)
- 3-D Printing/Advanced Manufacturing (6)
- Artificial Intelligence (5)
- Big Data (2)
- Bioenergy (5)
- Biology (6)
- Biomedical (10)
- Biotechnology (1)
- Chemical Sciences (2)
- Clean Water (2)
- Climate Change (1)
- Composites (1)
- Computer Science (13)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (4)
- Environment (6)
- Fossil Energy (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (11)
- Materials Science (20)
- Mathematics (1)
- Microscopy (2)
- Nanotechnology (8)
- National Security (2)
- Neutron Science (75)
- Nuclear Energy (2)
- Physics (8)
- Quantum Computing (1)
- Quantum Science (5)
- Security (2)
- Space Exploration (2)
- Summit (6)
- Transportation (3)
Media Contacts
Like most scientists, Chengping Chai is not content with the surface of things: He wants to probe beyond to learn what’s really going on. But in his case, he is literally building a map of the world beneath, using seismic and acoustic data that reveal when and where the earth moves.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Paul Langan will join ORNL in the spring as associate laboratory director for the Biological and Environmental Systems Science Directorate.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
Five researchers at the Department of Energy’s Oak Ridge National Laboratory have been named ORNL Corporate Fellows in recognition of significant career accomplishments and continued leadership in their scientific fields.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.